DGX EBITDA Growth
Quest Diagnostics · EBITDA Growth
DGX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported7.54%period ending
DGX TTM EBITDA YoY % (128.15% → 7.54%)
Year-over-year change
High-resolution chart · PNG
DGX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 7.5362% | |
| 14.3955% | |
| 14.8813% | |
| 20.1124% | |
| 18.1507% | |
| 12.0551% | |
| 9.4111% | |
| 11.1805% | |
| 6.4399% | |
| 5.9611% | |
| -4.7305% | |
| -27.3264% | |
| -34.16% | |
| -44.9983% | |
| -42.4501% | |
| -35.3769% | |
| -28.5714% | |
| 1.9788% | |
| 31.0245% | |
| 73.1336% | |
| 136.1673% | |
| 96.9758% | |
| 52.1136% | |
| 38.8575% | |
| 5.4804% | |
| 6.514% | |
| 13.2952% | |
| -2.8101% | |
| -2.4983% | |
| -3.8541% | |
| -3.7827% | |
| 0.7597% | |
| -2.0394% | |
| -6.4994% | |
| -1.6903% | |
| -0.4127% | |
| -16.8457% | |
| -2.9963% | |
| -5.1923% | |
| -8.4959% | |
| 45% | |
| 27.1429% | |
| 17.9138% | |
| 19.6551% | |
| -30.6811% | |
| -29.0534% | |
| -26.2124% | |
| -25.3812% | |
| 26.0384% | |
| 23.3038% | |
| 18.3215% | |
| 12.1885% | |
| -12.9064% | |
| -9.3257% | |
| 15.6725% | |
| 24.8422% | |
| 26.4744% | |
| 22.1887% | |
| -16.6579% | |
| -20.2821% | |
| -21.7892% | |
| -19.5255% | |
| -3.6373% | |
| -0.7289% | |
| 8.2031% | |
| 10.7096% | |
| 21.081% | |
| 17.8027% | |
| 10.7924% | |
| 17.7361% | |
| 16.1423% | |
| 23.0421% | |
| 23.5184% | |
| 6.008% | |
| -9.0954% | |
| -9.8289% | |
| -10.9665% | |
| -1.4888% | |
| 15.0692% | |
| 11.5778% | |
| 13.6849% | |
| 13.0128% | |
| 3.6209% | |
| 6.5408% | |
| 6.5215% | |
| 5.0821% | |
| 12.6997% | |
| 15.7056% | |
| 22.4638% | |
| 30.5912% | |
| 31.1851% | |
| 30.072% | |
| 30.1471% | |
| 28.8197% | |
| 29.4613% | |
| 34.9811% | |
| 29.6619% | |
| 24.7694% | |
| 23.6675% | |
| 14.0095% |